1.0100
-0.4900
(-32.67%)
At close: March 3 at 4:00:03 PM EST
1.0201
+0.01
+(1.00%)
After hours: 7:58:56 PM EST
Breakdown
TTM
12/31/2023
12/31/2022
Operating Cash Flow
-403.4510
87.0380
-142.9050
Investing Cash Flow
-75.9020
-75.9020
-4,895.1060
Financing Cash Flow
481.2970
--
4,852.5520
End Cash Position
16.5410
11.1740
0.0380
Capital Expenditure
-75.9020
-75.9020
-4,895.1060
Issuance of Capital Stock
257.6450
--
1,000
Free Cash Flow
-479.3530
11.1360
-5,038.0110
12/31/2022 - 4/11/2022
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
OSRH OSR Holdings, Inc.
2.6000
-14.47%
AEON AEON Biopharma, Inc.
0.6100
-18.67%
PBM Psyence Biomedical Ltd.
1.0300
-16.94%
TNFA TNF Pharmaceuticals, Inc.
0.3931
-5.98%
RNAZ TransCode Therapeutics, Inc.
1.9200
-3.03%
GTBP GT Biopharma, Inc.
2.3300
-2.10%
SCPX Scorpius Holdings, Inc.
0.1599
-6.49%
TCBP TC Biopharm (Holdings) Plc
1.9700
+1.03%
VINC Vincerx Pharma, Inc.
0.7601
-30.27%
BRTX BioRestorative Therapies, Inc.
1.5100
-0.66%